China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 19, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	186	34	1	3	11	29
Market Cap Growth	13335.50%	3514.19%	-67.93%	-73.95%	-60.15%	83.78%
Enterprise Value	161	26	-7	2	14	19
Last Close Price	1.54	2.49	13.44	56.72	1120.00	7360.00
PS Ratio	1.26	19.72	0.49	1.50	4.37	5.97
PB Ratio	1.37	2.22	0.07	0.20	0.69	1.79
P/TBV Ratio	11.58	2.23	0.07	0.20	0.69	1.79
P/FCF Ratio	-	-	-	-	55.27	-
P/OCF Ratio	-	-	-	-	42.40	-
EV/Sales Ratio	92.73	14.76	-	0.79	5.37	3.93
EV/FCF Ratio	-	-	-	-	67.88	-
Debt / Equity Ratio	0.06	0.06	0.27	0.61	0.65	0.76
Debt / FCF Ratio	-	-	-	-	52.20	-
Asset Turnover	0.08	0.08	0.07	0.06	0.08	0.17
Inventory Turnover	1.42	1.42	1.98	1.88	1.10	1.60
Quick Ratio	3.33	3.33	1.51	1.31	1.14	1.00
Current Ratio	3.54	3.54	1.60	1.35	1.31	1.25
Return on Equity (ROE)	-22.50%	-22.50%	-21.65%	-38.15%	-35.42%	-21.67%
Return on Assets (ROA)	-7.48%	-7.48%	-4.96%	-10.42%	-9.53%	-4.88%
Return on Capital (ROIC)	-9.84%	-9.84%	-6.34%	-12.93%	-11.73%	-6.20%
Return on Capital Employed (ROCE)	-17.10%	-17.10%	-14.70%	-34.90%	-31.60%	-13.80%
Earnings Yield	-1.85%	-9.62%	-326.13%	-200.33%	-50.43%	-9.63%
FCF Yield	-1.31%	-6.84%	-203.68%	-5.11%	1.81%	-4.94%
Buyback Yield / Dilution	-1212.67%	-1212.67%	-224.91%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q